Showing results (261-270 of 277) with videos related to
Sort By:
Pageof 28
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 6, 1999
Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's diseaseJ H Cha, A S Frey, S A Alsdorf, et al.Neuroimage|December 28, 2020
Using non-invasive neuroimaging to enhance the care, well-being and experimental outcomes of laboratory non-human primates (monkeys)M A Basso, S Frey, K A Guerriero, et al.The Journal of Infectious Diseases|November 7, 1998
A dose response study of hepatitis A vaccine in healthy adults who are > or = 30 years old and weigh > or = 77 kgJ S Bertino, S Thoelen, P VanDamme, et al.The British Journal of Dermatology|July 11, 2018
In situ biodistribution and residency of a topical anti-inflammatory using fluorescence lifetime imaging microscopyA Alex, S Frey, H Angelene, et al.Academic Pediatrics|February 11, 2026
Validity Evidence for STATUS To Assess Resident Tolerance for and Competence in Communicating Medical AmbiguityAriel S Frey-Vogel, Kevin Ching, Michael G Healy, et al.Analytical Chemistry|July 25, 2009
Interlaboratory trial on the analysis of alkylphenols, alkylphenol ethoxylates, and bisphenol A in water samples according to ISO/CD 18857-2E Stottmeister, O P Heemken, P Hendel, et al.Journal of Neurotrauma|October 14, 2016
Cerium Oxide Nanoparticles Improve Outcome after In Vitro and In Vivo Mild Traumatic Brain InjuryZachary S Bailey, Eric Nilson, John A Bates, et al.Nature|June 3, 1999
Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's diseaseV O Ona, M Li, J P Vonsattel, et al.Human Molecular Genetics|May 18, 2000
Decreased expression of striatal signaling genes in a mouse model of Huntington's diseaseR Luthi-Carter, A Strand, N L Peters, et al.Leukemia|August 27, 2015
NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cellsA K Jayavelu, J P Müller, R Bauer, et al.Pageof 28